Table of cases

Section last updated: April 2024.

Notes:

  1. For EPO decisions, see separate list below.

  2. “SHB” indicates a Secretariat Hearing Box number (old Office numbering system).

  3. The Reports of Patent, Design and Trade Mark Cases (RPCs) have been published since 1884. For those published between 1884 and 1955, the first number of the RPC citation refers to the Volume number, where Volume 1 was published in 1884, Volume 2 in 1885 etc. From 1956 onwards, the year is provided instead.

  4. In 2001, Sweet & Maxwell (then publishers of the RPCs on behalf of the Office) changed the way in which cases are cited. For citations up until the end of 2000, the final number of the citation refers to the page number in that year’s volume. From the beginning of 2001, the final number refers to case number in that year’s volume. This numbering system applies to the RPCs and to Sweet & Maxwell reports cited from the beginning of 2001, including FSRs and EPORs.

** recently added

Case Citation Manual Paragraph(s)  
4D Pharma’s Application BL O/202/21 20.02  
Abaco Machines (Australasia) Pty Ltd’s Application [2007] EWHC 347 (Pat) 130.34, 89.01, 5.26.4  
Abbott Laboratories (Chu’s) Patent [1992] RPC 487 72.26  
Abbott Laboratories Ltd. v Medinol Ltd [2010] EWHC 2865 (Pat) 14.171, 76.08.2  
AB Hassle’s Patent 1308106 (“metoprolol”) SHB 12, BL O/79/87 46.66.1, 46.75, 46.76.2  
Ability International Ltd v Monkey Tower Ltd BL O/484/14 75.15.1  
Abraham’s Patent 1302188 SHB 26, BL O/186/87 46.49  
ABT Hardware Ltd’s Application SHB 259, BL O/36/87 3.28.2  
Acumen Design Associates LTD BL O/131/17 14.120  
Actavis Group PTC EHF v Pharmacia LLC [2014] EWHC 2265 71.02  
Actavis Group PTC EHF v ICOS Corporation & Ors [2017] EWCA Civ 1671
[2019] UKSC 15
3.87.2, 125.17.7  
Actavis UK Ltd v Janssen Pharmaceutica NV [2008] EWHC 1422 [2008] FSR 35 4A.28  
Actavis UK Ltd v Merck [2008] RPC 26 0.10, 3.37.2, 4A.28.1-4A.28.2,130.31  
Actavis UK Ltd v Novartis AG [2010] EWCA Civ 82 3.99  
Actavis UK Ltd & Others v Eli Lilly & Company [2015] EWCA Civ 555, [2017] UKSC 48 60.19.2, 14.144, 2.03, 125.17.3-125.18.5, 125.26  
Adamson Jones IP Limited v American Isostatic Presses Inc BLO/00992/23 5.30  
Adgistics Ltd’s Application BL O/297/04    
Adhesive Dry Mounting Co Ltd v Trapp & Co 27 RPC 341 2.14  
Advocat Giovanni Gozzo AB’s Patent SHB 459, BL O/150/95 28.16  
Aerotel Ltd v Telco Holdings Ltd Ors Rev 1 (Aerotel/Macrossan) [2006] EWCA Civ1371; [2007] RPC 7 1.07, 1.08, 1.09.1, 1.10, 1.14, 1.18, 1.19, 1.21, 1.21.1, 1.25, 1.33-1.33.1, 1.33.2  
Aerotel Ltd v Wavecrest Group Enterprises Ltd & Ors [2008] EWHC 1180 (Pat) 1.20.1  
Agfa-Gevaert AG’s Application [1982] RPC 441 5.30  
Akebia Therapeutics Inc V Fibrogen Inc [2020] EWHC 866 (Pat) [2021] EWCA Civ 1279, [2021] EWCA Civ 1279 14.93.2, 125.17.9, 125.26.1 14.93.2, 14.88.1  
Akron Brass Company’s application BL O/012/19 20.02.1  
Albright & Wilson Ltd’s Patent SHB 378, BL O/190/92 73.11  
Ali et al’s Application BL O/264/10 20A.11.1  
Allen and Hanburys Ltd’s Patent 1266058 (“labetalol”) BL O/137/85 46.62  
Allen and Hanburys Ltd’s Patent 1200886 (“salbutamol”) [1987] RPC 327 46.31-32, 46.35-36, 46.38.1, 46.39-39.1, 46.47, 46.48, 46.53, 46.56, 46.58, 46.62  
Allen and Hanburys Ltd v Generics (UK) Ltd and Gist-Brocades NV and others and Comptroller General of Patents (“Gist Brocades”) [1986] RPC 203 [1988] FSR 312 46.02, 46.05-07, 46.20, 46.24, 46.27-29, 46.35, 46.53, 46.59, 46.78.1, 60.15  
Allen and Hanburys Ltd’s Patent 1429 184 SHB 86 46.38.2, 46.44, 46.71-72  
Allen and Hanbury v Generics [1988] FSR 312 46.53, 46.78.1, 60.15F  
Allmanna Svenska Elektriska AB’s Application [1976] RPC 464 72.14  
Allmanna Svenska Elektriska AB v The Burntisland Shipbuilding Co Ltd 69 RPC 63 3.04  
Alphaplan Ltd’s Application SHB 418, BL O/127/93 123.08  
Alps Electric Co’s Application SHB 311, BL O/12/90 15.08.1  
Amchem’s Products Inc’s Patent [1978] RPC 271 14.153  
Ament’s Application [1994] RPC 647 28.15.1  
American Cyanamid Co’s (Fenbufen) Patent [1990] RPC 309 [1991] RPC 409 46.35, 46.37, 46.38-38.1, 46.41, 46.45, 46.47.2, 46.56, 46.69.2-70  
American Cyanamid v Ethicon [1979] RPC 265 14.71, 14.87  
American Home Products Corp. v Novartis Pharmaceuticals Ltd [2001] RPC 8 4A.30, 4A.31, 14.82-14.84  
Ammonia’s Application 49 RPC 409 2.09  
Anan Kasei v Neo Chemicals [2019] EWCA Civ 1646 14.76, 14.80.1, 14.123.1  
Anan Kasei Co Ltd & Rhodia Operations SAS v Molycorp Chemicals & Oxides Ltd [2018] EWHC 843 (Pat) 14.123.1  
Ancare New Zealand Ltd’s Patent [2003] RPC 8 3.98  
Anderson’s Application BL O/112/12 1.32.1  
Angiotech Pharmaceuticals Inc’s Patent (Application for Revocation by Conor Medsystems Inc) [2006] RPC 28 3.87  
Angiotech Pharmaceuticals Inc v Conor Medsystems Inc [2007] RPC 20 [2007] EWCA Civ 5 3.46  
Anderson’s Application BL O/297/02 15.21  
Anning’s Application BL O/374/06 5.26.5, 20A.13, 20A.14, 28.09, 28.09.1  
Anning’s Patent Application [2007] EWHC 2770 (Pat) 20.02.2, 20A.02, 20A.11.1  
Apimed Medical Honey Ltd v Brightwake Ltd [2011] EWPCC 2, [2011] RPC 16 3.30.2  
Apple Inc’s Application BL O/244/13 1.38.5  
AP Racing Ltd v Alcon Components Ltd [2014] EWCA Civ 40 76.15.0  
Armaturjonsson AB’s Application [1985] RPC 213 123.45  
ARMCO Inc’s Application BL O/84/85 14.171, 76.08.2  
Armstrong-Kropp Development Corporation’s Applications [1974] RPC 268 18.96  
Arrow Electric Switches Ltd’s Applications 61 RPC 1 18.97  
Asahi Kasei Kogyo KK [1991] RPC 485 2.10.2, 5.23, 14.152, 76.08  
Ashland Oil Inc’s Patent 1190644 BL O/35/86 46.49  
Astron Clinica and other’s Applications [2008] EWHC 85 (Pat) RPC 14 1.13, 1.15.1,1.35  
AT&T Knowledge Ventures’ Application and CVON Innovations Ltd’s Application [2009] FSR 19 1.29.1, 1.37, 1.38.1, 1.38.3, 1.38.4  
atenolol see ICI    
Atlas Powder Co’s Patent [1995] RPC 666 28.15  
Auchincloss v Agricultural & Veterinary Supplies Ltd [1999] RPC 397 [1997] RPC 649 14.117, 60.24  
Aujla v Sanghera [2004] EWCA Civ 121 20.08  
Autonomy Corp Ltd v Comptroller General of Patents, Trade Marks & Designs [2008] EWCH 146 (Pat) 1.40  
Axis Genetics PLC’s (In Administration) Patent [2000] FSR 448 72.04.1  
Badische Anilin and Soda Fabrik v La Societe etc du Rhone 15 RPC 359 14.74  
Bancroft’s Application 23 RPC 89 14.140  
BASF AG v Praesident des Deutschen Patentamts [2001] 2 CMLR 435 77.13  
Bayer AG (Baatz’s) European Application [1982] RPC 321 3.88  
Bayer AG (Meyer’s) Application [1984] RPC 11 4A.19-4A.20  
Bayer AG’s Patent 1170188 (DDSA’s Application) BL O/139/85 46.73  
Bayer AG’s Patent 1173862 (“nifedipine”) (Generics’ Application) BL O/049/86 46.45, 46.48.1, 46.76.1  
Bayer AG’s Patent 1173862 (“nifedipine”)(Harris Pharmaceuticals’ Application) SHB 31, BL O/008/88 46.47.1  
Beloit Technologies Inc v Valmet Paper Machinery Inc [1995] RPC 705 [1997] RPC 489 6.02-03 3.33  
Bentley Engineering Co Ltd’s Patent [1981] RPC 361 27.08  
Bergwerksverband Gmbh’s Patent 1364 674 SHB 75, BL O/58/89 46.58, 46.64  
Bilgrey Samson Ltd’s Application BL O/577/01 14.136.1  
Biogen Inc v Medeva Plc [1997] RPC 1, [1995] RPC 25 1.04, 3.03, 4A.29.5, 5.23, 14.63, 14.79,14.149,14.83-14.84 72.03  
BioProgress Technology Limited v Stanelco Fibre Optics Limited BL O/351/03 8.29  
Blacklight Power Inc.’s Application Blacklight Power Inc. v The Comptroller-General of Patents (Patents Ct) BL O/170/09 [2009] RPC 6 4.05.2, 14.90 3.69, 4.05.1-4.05.2, 14.90, 18.09.2  
Blacklight Power Inc.’s Application BL O/076/08 1.28  
Blacklight Power Inc.’s Application BL O/114/08 1.28  
Bloomberg LLP and Cappellini’s Applications [2007] EWHC 476 (Pat), [2007] FSR 26 1.15.1  
Boehringer Mannheim GmbH v Genzyme Ltd [1993] FSR 716 3.77  
Bonzel & anr. v Intervention Ltd [1991] RPC 553 76.06, 76.07  
Book Protectors and Co’s Patent SHB 368, BL O/23/96 46.66.3  
Border’s Patent BL O/157/79 28.05  
Bradford Dyers Association Ltd’s Application [1966] FSR 79 72.16  
Braun AG’s Application [1981] RPC 355 27.24  
Bridgestone Tire KK’s Patent SHB 218, BL O/166/92 27.28  
Bristol-Myers Co’s Application [1969] RPC 146 2.24  
Bristol Myers Squibb Co. v Baker Norton Pharmaceuticals Inc (Patents Court) Bristol Myers Squibb Co. v Baker Norton Pharmaceuticals Inc (Court of Appeal) [1999] RPC 253 [2001] RPC 1 3.84, 4A.03.1, 4A.28, 4A.28.1-4A.28.2, 4A.31  
British Broadcasting Corporation’s Patent SHB 306, BL O/49/89 28.12  
British Celanese Ltd’s Application 51 RPC 192 14.122  
British Numberplate Manufacturers Association v Hills Numberplates Limited BL O/66/05 72.04  
British Ore Concentration Syndicate Ltd v Mineral Separation Ltd 26 RPC 124, 27 RPC 47 2.09, 3.31  
British Railways Board’s Patent 1179 723 SHB 103, BL O/041/85 71.04  
British Steel’s Patent 2174 029 SHB 97, [1992] RPC 117 40.03.1, 40.04.2  
British United Shoe Machinery Co Ltd v Simon Collier Ltd 26 RPC 48 14.154  
British United Shoe Machinery Co Ltd v A Fussell and Sons Ltd 25 RPC 651 14.109  
Brooks and Cope’s Application SHB 245, BL O/071/93 8.05.1, 10.07.1  
Brownie Wireless Co Ltd’s Applications 46 RPC 457 48A.05, 48B.11  
Brugger and Others v Medic-Aid Ltd [1996] RPC 635 3.39, 3.84  
Brupat Ltd v Smith [1985] FSR 156 65.05  
BSH Industries Ltd’s Patents [1995] RPC 183 2.12.4  
BTH Co Ltd’s Patent 53 RPC 255 27.30  
Buehler AG v Chronos Richardson Ltd [1998] RPC 609 72.04  
Buralls of Wisbech Ltd’s Applications [2004] RPC 14 118.20  
BWS Management’s Patent SHB 342, BL O/113/90 28.16  
Cabot Safety Corp’s Patent [1992] RPC 39 46.50.3, 46.60  
Cairnstores Ltd v Aktiebolaget Hassle [2002] FSR 35 72.04  
Calmic Engineering Co Ltd’s Application [1973] RPC 684 4A.03.1  
Cannings’ United States Application [1992] RPC 459 12.05  
Cantel Medical et al v Arc Medical [2018] EWHC 345 (Pat) 75.12  
Cappellini see Bloomberg    
carboplatin see Research Corp    
Cartonneries de Thulin SA v CTP White Knight Ltd [2001] RPC 6 14.113, 76.14  
Cartwright’s Patent SHB 243, BL O/74/93 37.19  
Cassidy v Eisenmann & Co Ltd [1980] FSR 381 110.05  
Cassou’s Patent [1971] RPC 91 46.11-12, 46.49, 46.76.2, 47.06  
Cathro’s Application 51 RPC 475 48B.05  
Cathro’s Applications 51 RPC 75 48A.02, 48B.07  
Catnic Components Ltd and another v Hill and Smith Ltd [1982] RPC 183, [1983] FSR 512 14.115-14.117, 125.13, 125.17.5-125.17.6  
Cayless & Sci Sport Limited v Barton & Cullis BL O/073/98 74.07  
Cellartis AB’s Application BL O/050/11 125A.05.1  
Cement and Concrete Association’s Patent [1984] RPC 131 28.11  
Cephalexin see Eli Lilly      
CFPH LLC’s Application [2005] EWHC 1589 (Pat) [2006] RPC 5 1.20.2, 1.27  
Chemische Fabrik auf Aktien’s Application 45 RPC 403 14.154  
Chiron Corp v Organon Teknika Ltd [1993] FSR 324, 567 [1994] FSR 202, [1994] FSR 258, [1995] FSR589 44.10, 3.79, 14.67.1, 14.80, 14.87, 14.152, 75.01, 75.01  
Chiron Corp and ors v Murex Diagnostics Ltd and ors [1996] RPC 535 4.02, 14.80  
Chitolie’s Application BL O/078/04, [2004] EWHC 1549 (Ch) 123.38  
Ciba-Geigy AG’s Application SHB 192, BL O/30/85 4A.03.2  
Ciba-Geigy AG (Durr’s) Application [1977] RPC 83 1.40.3  
Ciba-Geigy AG’s Patent 1146173 [1986] RPC 403 46.52-53  
Ciba-Geigy AG’s Patent 1255258 (Agan/Alpha’s Application) BL O/85/86 46.57  
Ciba-Geigy AG’s Patents 1255258 and 1407587 (Portman Agrochemicals Application) BL O/159/86 46.57, 46.60, 46.69  
Cimetidine see Smith, Kline and French    
Cipla Ltd v Glaxo Group Ltd [2004] RPC 43 3.81.2  
Citizen Watch Ltd’s Patent [1993] RPC 1 73.08, 73.11  
Claydon V Mzuri [2021] EWHC 1007 (IPEC) [2.27.1](/guidance/manual-of-patent-practice-mopp/section-2-novelty/#ref2-27-1  
Clear Focus Imaging Inc. v Contra Vision Ltd Patents Court, 16th November 2001, unreported 27.29  
Clevite Corporation’s Patent [1966] RPC 199 27.07  
Coal Industry (Patents) Ltd’s Patent [1994] RPC 661 27.08  
Coal Industry (Patents) Ltd’s Application [1986] RPC 57 123.06  
Coal Industry’s Patent SHB 108, BL O/11/90 118.13  
Coco v A N Clark (Engineers) Ltd [1969] RPC 41 2.38  
Coflexip Stena Offshore Ltd’s Patent [1997] RPC 179, SHB 382, BL O/67/96 32.08, 46.76.1  
Colbourne Engineering Co Ltd’s Application 72 RPC 169 48A.04, 48B.10  
Colley’s Application [1999] RPC 97 2.29.1  
Commonwealth Scientific and Industrial Research Organization’s Application BL O/248/04 4A.02  
Commonwealth Scientific and Industrial Research Organisation’s Application BL O/367/11 1.38  
Communication & Control Engineering Company Ltd’s Patent SHB 246, BL O/82/93 40.05  
Conor Medsystems Inc v Angiotech Pharmaceuticals Inc [2008] RPC 28 3.87  
Consultant Suppliers Ltd’s Application [1996] RPC 348 14.152  
Continental Manufacturing & Sales Inc’s Patent [1994] RPC 535 28.10  
Contra Vision Limited’s Patent BL O/079/00 14.140  
Convex Ltd’s Patent [1980] RPC 423 28.13  
CoreValve Inc v Edwards Lifesciences AG & Anor [2009] EWHC 6 (Pat), [2009] FSR 8 60.24  
Courtauld’s Application [1956] RPC 208 67.04  
Critchley v Engelmann [1971] RPC 346 27.21  
Cummins-Allison Corp’s Application BL O/361/12 1.33.2  
Curt G Joan Inc v Fameccanica Data SpA [2017] EWHC 1251 (IPEC) 75.12  
Cyprane’s Patent 1224478 SHB 44, BL O/108/88 46.50.2  
Cypress Semiconductor Corporation’s Application BL O/326/16 123.10.3  
Daido Kogyo KK’s Patent [1984] RPC 97 28.04, 28.17  
Daihatsu Motor Co Ltd and others’ Patent BL O/234/14 123.47.1  
Datacard Corp. v Eagle Technologies Ltd [2011] EWHC 244 (Pat), [2011] RPC 17 3.34.2, 76.15.4  
Degussa-Huls AG v The Comptroller-General of Patents [2005] RPC 29 3.48, 3.64  
Dell Products LP’s Application BL 0/321/10 1.09.3  
Diamond Shamrock Technologies SA’s Patent [1987] RPC 91 118.13  
Diltiazem see Tanabe Seiyaku    
Direct TV Pty’s Application BL O/150/11 1.38.5  
* DLP Ltd’s Patent [2008] RPC 11 14.113.1  
Dow Chemical Company’s Application SHB 136, BL O/175/83 14.159.1  
Dow Chemical Company (Mildner’s) Patent [1973] RPC 804 3.42, 3.44  
Dow Corning Corporation (Bennett’s) Application [1974] RPC 235 1.40.3  
Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Co Ltd (Patents Court) [2008] EWHC 2345 (Pat), [2009] FSR 5 2.03.1, 3.81.2  
Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Co Ltd (Court of Appeal) [2010] RPC 9 2.06-2 2.19, 3.89-3.90  
DSM NV’s Patent (EP0420358) [2001] RPC 35 3.14, 14.82, 76.10  
DST SA’s Patent 1195871 BL O/152/85 46.62, 46.66-46.66.1  
Dukhovskoi and Others’ Applications [1985] RPC 8 117.09  
Du Pont de Nemours & Co (Witsiepe’s) Application [1982] FSR 303 2.19, 2.20, 3.92  
Du Pont de Nemours’ (Blades) Patent [1988] RPC 479, 497 46.69.1  
Dust Suppression Ltd’s Application [1976] FSR 438 72.13  
Dynamics Research and Manufacturing Inc’s Patent [1980] RPC 179 28.03  
Dyson Appliances Ltd v Hoover Ltd [2001] RPC 26, [2002] RPC 22 3.07, 3.22, 3.25, 3.72, 3.97  
Dyson Ltd’s Patent [2003] RPC 24, [2003] RPC 48 29.03  
Dyson Ltd’s Trade Mark Application [2003] RPC 47 97.03  
Dytap Revetments’ Patent SHB 17, BL O/76/87 28.16  
E’s Applications [1983] RPC 231 123.08, 130.32  
Eastman Kodak Co. v American Photo Booths Inc BL O/457/02 4.05, 14.90  
Ebrahim Shahin’s Application BL O/149/95 1.40.2  
Edison and Swan Electric Light Co v Holland 6 RPC 282 14.68  
A C Edwards v Acme Signs & Displays Ltd [1990] RPC 621 [1992] RPC 131 14.151, 76.07, 76.08, 76.13.1, 76.15  
Edwards Lifesciences AG v Cook Biotech Inc [2009] EWHC 1304 (Pat); [2009] FSR 27 5.19-5.19.1  
Eickhoff Maschinenfabrik’s Patent SHB 10, BL O/31/87 75.15  
Electricité de France (EDF)’s Patents [1992] RPC 205 28.03  
Eli Lilly’s Patent 1277137 (“cephalexin”) SHB 10, BL O/69/87 46.43, 46.45, 46.75  
Eli Lilly & Co. v Human Genome Sciences, Inc. [Patents Court] [2008] EWHC 1903 (Pat), [2008] RPC 29 3.51.1, 4.07.2, 14.60, 14.85  
Eli Lilly & Co. v Human Genome Sciences, Inc. [Court of Appeal] [2010] EWCA Civ 33 [2010] RPC 14 4.07.2  
Eli Lilly & Co v Janssen Alzheimer Immunotherapy [2013] EWHC 1737 4A.29.2  
El-Tawil’s Application [2012] EWHC 185 4A.28, 4A.29  
* Emotional perception AI Ltd v Comptroller-General of Patents, Designs and Trade Marks [2023] EWHC 2948 (Ch) 1.39.4  
Emson V Hozelock Ltd & Others [2019] EWHC 991 2.27.1  
Emson V Hozelock [2020] EWCA CIV 871 3.39.2, 3.79.1, 3.81.3  
Emulsol Corporation’s Patent 57 RPC 256 27.15  
* Ensygnia v Shell [2023] EWHC 1495 (Pat) 76.20.1  
Enviro-Spray Systems Inc’s Patents [1986] RPC 147 48B.03, 50.07  
EPS Research’s Patent SHB 387, BL O/53/92 28.15.1  
Esau’s Application 49 RPC 85 14.152-14.153  
European Commission v United Kingdom [1992] 2 CMLR 709 50.05  
European Court of Justice [1988] FSR 312 46.53, 46.78.1, 48.15, 60.15  
Evans Medical Ltd’s Patent [1998] RPC 517 2.29, 5.23.2  
Eveready Battery Company Inc.’s Patent [2000] RPC 852 123.06  
Extrude Hone Corp’s Patent [1982] RPC 361 48.15  
Fabio Perini SPA v LPC Group plc and others [2010] EWCA Civ 525 14.112-113  
Facebook Ireland Ltd v Voxer IP LLC [2021] EWHC 1377 (Pat) 125.17.8  
Farmitalia Carlo Erba SpA’s Patent 1249443 SHB 53 46.48  
Fater’s Application [1979] FSR 647 123.08  
Fellerman’s Application SHB 362, BL O/11/96 40.03.2  
Fergusson’s Application BL O/272/09 15.21  
Fenbufen see American Cyanamid    
FH Brundle v Perry [2014] EWHC 475 (IPEC) 2.12.3, 70.04  
Fichera v Flogates Ltd [1984] RPC 257 44.02, 44.06-07, 44.10, 44.12  
Filpin Filpost Ltd v Fairfax (Dental Equipment) Ltd SHB 230, BL O/007/93 46.37.3  
Firma Carl Kurt Walther’s Patent 1368 039 SHB 108 46.49, 46.66, 46.66.3  
Fisher Rosemount Systems’ Application BL O/238/12 18.63.3  
Fisher Rosemount Systems’ Application BL O/346/19 1.37.3  
Fisher Westmoreland’s Patent SHB 349, BL O/151/90 28.16  
Fletcher’s Application BL O/235/98 89.06, 89.09  
Flexible Direction Indicators Ltd’s Application [1994] RPC 207 76.12  
Florey and others’ Patent [1962] RPC 186 36.04  
Flour Oxidizing Co Ltd v Carr & Co Ltd 25 RPC 428 2.17  
Flude (H) & Co (Hinckley) Ltd’s Patent [1993] RPC 197 72.25  
Folding Attic Stairs Ltd v Loft Stairs Co. Ltd. [2009] FSR 24 2.27.1, 14.129  
Ford Motor Co Ltd (Cuskie’s) Application [1973] RPC 573 46.16  
Foseco International Ltd’s Patent [1976] FSR 244 27.21  
Francis’ Patent 1371 994 SHB 316, BL O/154/82 28.13  
Frazer’s Patent [1981] RPC 53 28.11, 28.12  
Frosst’s Patent 1253709 (“timolol”) SHB 15, BL O/84/87 46.74-75  
Fujitsu Limited’s Application [1996] RPC 507, [1997] RPC 608 1.18.1  
Fujitsu Limited’s Application BL O/121/04    
Furuno Electric Co. Ltd’s Application BL O/208/10 123.10.2  
Future New Developments Ltd v B & S Patente Und Marken GmbH [2014] EWHC 1874 (IPEC) 130.05.2  
Gale’s Application [1991] RPC 305 1.18.1, 1.29.4, 1.37.1, 1.39.3  
Garmin (Europe) Ltd v Koninklijke Philips N.V 2019] EWHC 107 3.17  
Gebhardt’s Patent SHB 128, [1992] RPC 1 48B.05, 48B.17  
GEC’s Application 60 RPC 3 2.14  
GEC Avery Service Ltd v Derwent Measurement and Control Ltd SHB 286, BL O/62/94 72.14  
GEC Avionics Ltd’s Patent [1992] RPC 107 40.03.1, 40.04.2  
Gedeon Richter v Bayer Schering [2011] EWHC 583 (Pat) 3.87.2  
Geigy SA’s Patent [1964] RPC 391 46.39, 46.45  
Geigy SA’s Patent [1966] RPC 250 48.19  
Gemstar–TV Guide International Inc v Virgin Media Limited [2009] EWHC 3068 (Ch), [2010] RPC 10 1.37, 1.40.4  
Genentech Inc’s Applcation Patent [1989] RPC 147
[1989] RPC 205
1.21, 1.27, 3.09, 3.27, 14.152, 27.11, 91.02  
Genentech Inc’s Patent BL O/360/14 29.03  
Genentech Inc v The Comptroller General of Patents (Hearing)

(Court of Appeal)
O/111/20

[2020] EWCA Civ 475
117.06.1  
General Electric Co Ltd’s Application [1961] RPC 24 14.152  
General Motors Corporation (Longhouse’s) Application [1981] RPC 41 14.200  
General Motors (Tunney & Barr’s) Application [1976] RPC 659 72.24  
General Tire and Rubber Company v Firestone Tyre and Rubber Company Limited [1972] RPC 457 2.03, 2.07.1, 3.20, 3.32  
Generics (UK) v Smith Kline & French [1993] 1 CMLR 89 46.54  
Generics (UK) Limited and others v H Lundbeck A/S [2007] EWHC 1040, [2007] RPC 32 3.81.2  
Generics (UK) Limited and others v H Lundbeck A/S [2009] UKHL 12, [2009] RPC 13 2.08.3, 3.34.1, 14.67.1, 14.80.1  
Generics (UK) Ltd (t/a Mylan) v Warner-Lambert Company LLC
(Patents Court)
(Court of Appeal)
[2015] EWHC 2548
[2016] EWCA Civ 1006
3.30.3, 4A.27.1, 4A.31, 60.16.1, 60.19.2  
Generics [UK] LTD (t/a Mylan) v Yeda Research and Development co. LTD & Anor [2013] EWCA Civ 925 3.89, 3.91.1  
Generics (U.K.) Limited and others v Yeda Research and Development Company Limited and others [2017] EWHC 2629 (Pat) 2.03, 125.17.7  
Georgia Pacific Corp’s Application [1984] RPC 467 8.21.2  
Gerber Garment Technology Inc’s Patent SHB 398, BL O/99/96 46.47  
J Gibbons Ltd’s Application [1957] RPC 158 27.28  
Gist-Brocades see Allen and Hanburys    
Glatt’s Application [1983] RPC 122 14.149, 14.151, 76.19, 125.04  
Glaverbel SA v British Coal Corporation and anr [1995] RPC 255 2.03.1, 14.113  
Glaxo Group Ltd v Genentech Inc [2008] EWCA Civ 23, [2008] FSR 18 71.02  
Glaxo Group’s Patent [2004] RPC 43 3.91, 3.96, 3.98  
Goddin and Rennie’s Application [1996] RPC 141 8.08.2  
Grace’s Patent 1307054 SHB 109 46.66.4  
Gram’s Patent BL O/412/99 28.12  
Green’s Application BL O/087/09 20A.14.1  
Grimme v Scott [2010] EWCA Civ 1110 60.19  
Guardall Ltd’s Patent SHB 394, BL O/91/96 27.08  
Haberman v Jackel [1999] FSR 685 3.75, 3.81  
Halcon SD Group Inc’s Patent BL O/94/85 28.11  
Halcon SD Group Inc’s Patents [1989] RPC 1 48.20  
Hallen Co v Brabantia (UK) [1990] FSR 134, [1991] RPC 195 62.09, 3.07, 3.24, 3.72, 3.95  
Halliburton Energy Services Inc v Smith International (North Sea) Ltd [2006] RPC 2, [2005] EWHC 1623 1.31.2, 2.29, 3.27, 14.65, 14.67.1, 14.70, 14.87, 14.93.1, 14.117.1, 60.16  
Halliburton Energy Services Inc v Smith International (North Sea) Ltd [2006] EWCA Civ 1715 14.70  
Halliburton Energy Services Inc’s Applications [2011] EWHC 2508 (Pat), [2012] RPC 129 1.16, 1.29.1, 1.31-1.31.3, 1.34, 1.35  
Halpern & Ward’s Patent BL C/14/93 28.15.1  
Harding’s Patent SHB 134, BL O/94/90 75.15  
Harris’ Patent [1985] RPC 19 39.09, 10  
Hartington Conway Ltd’s Patent Applications [2004] RPC 6, [2004] RPC 7 30.08, 130.22.1, 61.01, 97.03  
Hawker Siddeley Dynamics Engineering Ltd v Real Time Developments Ltd [1983] RPC 395 61.07, 71.10  
Heatex Group Ltd’s Application [1995] RPC 546 5.26.4, 5.26.5, 20A.13, 20A.14, 28.09, 28.09.1, 123.37  
Henry Brothers (Magherafelt) Ltd. v The Ministry of Defence and the Northern Ireland Office [1999] RPC 442, [1997] RPC 693 7.12, 7.12.2, 8.06, 36.06, 72.03.1  
Hewlett-Packard’s Application BL O/319/11 1.38.1  
Hewlett-Packard Development Company’s Application BL O/441/12 1.33.2  
Hickman v Andrews [1983] RPC 147 2.13, 3.80  
Hickton’s Patent Syndicate v Patents & Machine Improvements Co Ltd 26 RPC 339 1.27  
Hilti’s Patent 1217908 (Bauco (UK)’s Application) BL O/170/86 46.63  
Hilti’s Patent 1217908 (Structural Fastenings Group Ltd’s Application) [1988] RPC 51 46.50, 46.58, 46.60 61, 46.67  
H.Lundbeck A/S v Norpharma SpA [2011] EWHC 907 (Pat), [2011] RPC 23 2.07, 68.06, 68.07  
Hoechst Celanese Corp v BP Chemicals [1999] FSR 319 125.05  
Hoerrmann’s Application [1996] RPC 341 14.152  
Ho and Wang’s Patent SHB 30, BL O/152/87 28.12  
Hoffmann-La Roche’s Patent [1969] RPC 504 46.55.2  
Hollister Inc’s Application [1983] RPC 10 17.106  
Holywell Mining Group Ltd’s Patent 1297787 SHB 34, BL O/47/88 46.49, 46.58, 46.60, 46.64  
Hospira UK Generics (UK) Ltd (t/a Mylan) v Novartis AG [2013] EWCA Civ 1663 5.23.1  
Hospira UK Ltd v Genentech Inc [2014] EWHC 1094 4A.29.3, 4A.30.1, 4A.31, 5.23.2  
HSBC France’s Application BL O/180/09 18.09.4  
Hsuing’s Patent [1992] RPC 497 27.07, 27.08  
HTC Europe Co Ltd v Apple Inc [2013] EWCA Civ 451 1.09.2, 1.09.3, 1.18.1, 1.36.2, 1.36.3, 1.37, 1.37.2, 1.39.2  
Hughes v Paxman [2006] EWCA Civ 818; [2007] RPC 2, BL O/217/08 36.07  
Human Genome Sciences v Eli Lilly [2011] UKSC 51, [2012] RPC 6 0.09, 1.09, 4.07.2 C
IBM Corporation’s Application [1970] RPC 542 14.72  
IBM Corporation (Barclay and Bigar’s) Application [1983] RPC 283 18.94, 18.96  
Icescape Ltd v Ice-World International BV & Ors [2018] EWCA Civ 2219 125.17.6  
ICI Ltd’s Application SHB 5, BL O/73/82 4A.05
ICI Ltd (Richardson’s) Application [1981] FSR 609 4A.14, 14.126
ICI Plc v Ram Bathrooms Plc and Rohm GmbH [1994] FSR 181 75.05
ICI’s Patent 1285038 (“atenolol”) (Harris Pharmaceuticals ‘Application) BL O/59/86, BL O/82/86 46.25, 46.47.1
ICI’s Patent 1285038 (“atenolol”)(Thomas Kerfoot’s Application) SHB 16,BL O/91/87 46.19
IG Farbenindustrie AG’s Patents 47 RPC 289 2.14, 3.90
IGT’s applications [2007] EWHC 1341 (Ch) 1.32
IGT/Acres Gaming Inc.’s Application [2008] EWHC 568 1.20,14.129.1
Improver Corp v Remington Consumer Products Ltd [1990] FSR 181 125.18
Innovation Sciences Pty Ltd’s Application BL O/315/12 1.29.3
Intel Corporation’s Patent [2002] RPC 48 27.27.1
Intera Corporation’s Application [1986] RPC 459 16.02
Interfilta (UK) Ltd’s Patent [2003] RPC 22 101.06
FIntermec Inc’s Application BL O/769/18 15.07, 117.09.1
International Barrier Corporation’s Application 8211557 SHB 61 15.21
International Playtex Corporation’s Application [1969] RPC 362 76.18
Intuit Inc’s Application BL O/347/10 1.38.2
Inventa AG’s Application [1956] RPC 45 3.94
IPcom GmbH & Co Kg v HTC Europe Co Ltd & Ors [2013] EWCA Civ 1496 61.07, 71.02
IPCom GmbH v Vodafone [2020] EWHC 132 (Pat)

[2021] EWCA Civ 205
55.04, 55.05.1, 56.03

55.05.1
Irwin Industrial Tool Company’s Application BL O/247/09 15.46
ITS Rubber Ltd’s Application [1979] RPC 318 1.30.1
ITT Industries Inc’s Application [1984] RPC 23 18.86.3, 25.03, 123.39
Jade (The) [1976] 1 All ER 920 130.31-32
Jamesigns (Leeds) Ltd’s Application [1983] RPC 68 3.38
James Gibbons Ltd’s Application [1957] RPC 158 27.28
Jansen Betonwaren B.V. v Ian Robbie Christie BL O/496/15 14.125.1
Jarden Consumer Solutions (Europe) Ltd v SEB SA & Anor [2014] EWCA Civ 1629 14.135
Jaskowski’s Application [1981] RPC 197 18.55, 18.57
JDA Software Group Inc’s Application BL O/386/12 1.38.4
John Lahiri Khan’s Application BL O/356/06 1.33.2, 4.03
Johns-Manville Corporation’s Patent [1967] RPC 479 3.83
Johnson Matthey PLC v Sumitomo Special Metals Co Ltd BL O/168/92, BL O/145/94 71.02, 71.04.1
Joos v Commissioner of Patents [1973] RPC 59 4A.04
Jushi Group Co. Ltd v OCV Intellectual Capital LLC [2018] EWCA Civ 1416 2.06.2
Kalman and another v PCL Packaging (UK) Ltd and another [1982] FSR 406 60.19.1
Kamborian’s Patent [1961] RPC 403 48A.07, 48B.04, 48B.15
Kapur v Comptroller-General of Patents [2008] EWHC 649 (Pat) 1.15
Kavanagh Balloons Pty Ltd v Cameron Balloons Ltd [2004] RPC 5 2.29.1, 18.09.4
KCI Licensing Inc & Ors v Smith & Nephew Plc & Ors [Patents Court] [Court of Appeal] [2010] EWHC 1487, [2010] EWCA Civ 1260 3.33.2, 60.19,
Kelly & Anor v GE Healthcare Ltd [2009] EWHC 181(Pat), [2009] RPC 12 40.04, 40.04.3, 41.05
ketoprofen see Rhone-Poulenc  
Kimberly-Clark Worldwide Inc’s Patent BL O/279/04 18.97
Kimberly-Clark Worldwide Inc v Procter & Gamble Ltd [2000] RPC 422 75.04, 27.07
Kirin-Amgen Inc v Roche Diagnostics GmbH (Patents Court), [2002] RPC 1, 2.03.1, 14.66, 14.112
Kirin-Amgen Inc v Transkaryotic Therapies Inc (Ct of Appeal), [2003] RPC 3, 14.84, 62.13, 72.03,
Kirin-Amgen Inc v Hoechst Marion Roussel Ltd (House of Lords) [2005] RPC 9 1.27.1, 2.15, 3.34.1, 14.67.1, 14.76, 14.84, 14.86, 14.103, 14.112, 14.121-122
Kiwi Coders Corporation’s Application [1986] RPC 106 15.21
Klein Schanzlin & Becker AG’s Application [1985] RPC 241 5.08, 117.01
Klinische Versuche (Clinical Trials) I [1997] RPC 623 60.24
Klinische Versuche (Clinical Trials) II [1998] RPC 423 60.24
Knauf Insulation’s Application BL O/098/13 15.21
Kokusai Denshin Denwa’s Application SHB 66, BL O/009/83 15.21
Koninklijke Philips Electronics NV v Nintendo of Europe GmbH [2014] EWHC 1959 (Pat) 76.15.0
labetalol see Allen and Hanburys  
L’Air Liquide Societe’s Application 49 RPC 428 2.12
L’Oréal Ltd v RN Ventures Ltd [2018] EWHC 173 (Pat) 75.12 125.26
Lalvani et al’s Patent BLO/220/13 3.13.1
Lancer Boss v Henley Forklift [1975] RPC 307 62.03
Lantana v Comptroller-General of Patents [2013] EWHC 2673 (Pat) 1.12, 1.38.1, 1.38.5
Lantana v Comptroller-General of Patents [2014] EWCA Civ 1463 1.17.2, 1.21, 1.21.2, 1.38.5
La Soudure Electrique Autogene SA’s Application 56 RPC 218 5.05
Latchworth Ltd’s Patent SHB 471, BL O/112/96 28.16
Lee Pharmaceutical’s Applications [1978] RPC 51 4A.05
Lenovo (Singapore) PTE Ltd v Comptroller General of Patents [2020] EWHC 1706 (Pat) 1.09.4, 1.20.3, 1.21. 1.34.1, 1.38.1
Leonard’s Application [1966] RPC 269 14.138
Lermer Gmbh’s Patent SHB 462, BL O/14/96 28.15
Les Laboratoires Servier & Anor v Apotex Inc & Ors (Rev 1) [2014] UKSC 55 61.04.3
Letraset Ltd v Rexel Ltd [1974] RPC 175 5.24
Lever Bros’ Patent [1955] RPC 198 27.21
Lichtenstein’s Patent 1434 786 SHB 320, BL O/152/83, BL O/34/84 28.12
LIFFE Administration and Management v Pavel Pinkava [2007] RPC 30 39.09-11
LIFFE Administration and Management v Pavel Pinkava and De Novo Markets Limited [2006] EWHC 595 (Pat) 39.10
Ling’s Patent and Wilson’s and Pearce’s Patent [1981] RPC 85 28.11, 28.13
Linkrose Ltd’s Patent SHB 344, BL O/117/90 28.14
Liversidge v British Telecommunications plc [1991] RPC 229 72.03
Loadhog Ltd. v Polymer Logistics BV BL O/195/10 2.27.1
Loewe Radio Co Ltd’s Applications 46 RPC 479 48A.04, 48B.10
Lowndes’ Application SHB 400, BL O/19/93 76.04.1
Lowndes’ Patent 45 RPC 48 2.09
Lucas (Batteries) Ltd v Gaedor Ltd [1978] RPC 297 2.27.1
Lubrizol Corpn v Esso Petroleum [1993] FSR 64 280.04
Lubrizol Corporation v Esso Petroleum Co. Ltd. [1997] RPC 195, [1998] RPC 727 14.113, 64.04
Luk Lamellan und Kupplungsbau GmbH’s Application [1997] RPC 104 15.21, 15.46
Luthy’s Patent 1550 385 SHB 325 28.12
Lux Traffic Controls Ltd v Pike Signals Ltd and Faronwise Ltd [1993] RPC 107 1.17, 2.27
* Luxim Corp v Ceravision Ltd [2007] EWHC 1624 (Ch)
[2007] RPC 33
8.30
M’s Application [1985] RPC 249 123.09, 123-10
Maag Gear Wheel and Machine Co Ltd’s Patent [1985] RPC 572 18.96, 18.97
Mabuchi Motor KK’s Patents [1996] RPC 387 75.05
MacMullen’s Application BL O/307/03 123.37
Macrossan’s Patent Application [2006] EWHC 705 (Ch) 1.15.1, 1.33, 18.09.1, 18.09.2
Magill’s International Application BL O/256/00 12.04
Magnesium Elektron Ltd v Molycorp Chemicals & Oxides (Europe) Ltd & Anor [2015] EWHC 3596 100.04.1
Mallory Metallurgical Products Ltd v Black Sivalls & Bryson Inc [1977] RPC 321 71.04
Marbourn’s Patent BL O/376/99 28.11
Marconi v British Radio Telegraph and Telephone Co Ltd (1911) 28 RPC 181 60.09
Markem Corp v Zipher Ltd [2005] RPC 31 7.12.1, 8.09, 74.03.2
Marley (UK) Ltd’s Patent [1994] RPC 231 18.96
Marshall’s Application [1969] RPC 83 72.08
Masterman’s Design [1991] RPC 89 1.41
Matsushita Electric Industrial Co. v Comptroller General of Patents [2008] EWHC 2071 (Pat) 5.26.6, 20A.15, 28.09.2
Mayne Pharma v Debiopharm and Sanofi- Synthélabo [2006] EWHC 1123 (Pat) 14.75
Maxluck Biotechnology’s Application BL O/130/10 3.33.1
McDonald’s Application SHB 465, [BL O/71/96] 18.56
Mead’s Patent [1980] RPC 146 28.14
Medimmune Ltd v Novartis Pharmaceuticals UK Ltd, Medical Research Council [2011] EWHC 1669 (Pat) 14.61
Melia’s Application BL O/153/92 1.33.2, 4.03
Melkris Ltd v Denman BL O/369/01 71.04.1
Memco-Med Ltd’s Patent [1992] RPC 403 40.04.1, 40.04.2, 40.05
Memcor Australia Pty Ltd v Norit Membraan Technologie BV [2003] FSR 43 2.29.1
Menashe Business Mercantile Ltd v William Hill Organization Ltd [2003] RPC 31 60.19.1
Mentor Corporation v Hollister Inc [1993] RPC 7 14.64, 14.69, 14.71, 14.87
Merck & Co Inc’s Patent [2004] FSR 16 76.15.6, 97.03
Merck Sharp & Dohme Corp v Teva UK Ltd [2011] EWCA Civ 382 3.39.1
Merrell Dow Pharmaceuticals v N H Norton [1996] RPC 76 0.09, 1.09, 1.10.1, 2.04.2, 2.29, 130.31
Merrell Dow Pharmaceuticals v N H Norton BL C/89/96 76.04.1, 76.14, 76.25
Merrill Lynch’s Application [1989] RPC 561 1.15.1, 1.18.1, 1.22, 1.23, 1.34
Metabiotech’s Application BL O/0359/23 20.02
metoprolol see AB Hassle  
Meunier’s International Application BL O/013/01 89A.05, 123.37
Microsonics Corporation’s Applications [1984] RPC 29 2.25
Milliken Denmark AS v WalkOff Mats Ltd and anr [1996] FSR 292 2.27
Mills’ Application [1985] RPC 339 123.10
Ministry of Agriculture, Fisheries and Food’s Patent SHB 68, BL O/11/92 27.08, 27.31
Minnesota Mining and Manufacturing Co v Birtles, Lovatt and Evode Ltd BL O/237/00 7.12.2
Minnesota Mining and Manufacturing Co and anr v Plastus Kreative AB and anr BL C/64/95, [1997] RPC 737 14.115
Minnesota Mining and Manufacturing Co v Rennicks (UK) Ltd [1992] RPC 331 3.79
Minnesota Mining & Manufacturing Co.’s [1999] RPC 135 14.80, 14.115
(Suspension Aerosol Formulation) Patent   71.04
Mitsui Engineering & Shipbuilding Co’s Application [1984] RPC 471 15.08
MMD Design & Consultancy Ltd’s Patent [1989] RPC 131 71.04.1, 71.07
Molnlycke AB v Procter & Gamble Ltd [1994] RPC 49 3.06, 3.34, 14.67.1, 33.06, 62.10
Monkey Tower Ltd v Ability International Ltd [2013] EWHC 18 (Pat) 72.43
Monsanto Co v Stauffer Chemical Co and another [1985] RPC 515 60.24, 60.31
Monsanto (Brignac’s) Application [1971] RPC 153 2.24
Monsanto’s CCP Patent [1990] FSR 93 48.09, 48.15, 48A.05, 48B.11
Monsanto’s Patent 1366379 SHB 21, BL O/116/87 46.18
Monsanto Technology LLC v Cefetra BV et al ECJ Case C-428/08 60.06, 76A.08-08.1
Montgomerie Reid’s Application SHB 100, BL O/145/83 48.18, 52.03
Morton-Norwich Products Inc and others v Intercen Ltd [1981] FSR 337 67.05
M-Systems Flash Disk Pioneers Ltd v Trek Technology (Singapore) Pte Ltd BL O/318/06 130.26, 14.127
Munchkin’s Application BL O/623/17 20.02
Mutoh Industry Ltd’s Application [1984] RPC 35 3.28.2
MWUK Ltd v Fashion at Work Ltd BL O/531/16 27.09.1
Nakumura’s Patent 1513 967 SHB 324, BL O/121/84 28.13
Napp Pharmaceutical Holdings Ltd v Dr Reddy’s Laboratories (UK) Ltd [2016] EWCA Civ 1053 14.117.4
naproxen see Syntex  
National Starch and Chemical Investment Corp’s Application SHB 463A, BL O/34/96 18.07.2
NEC Corporation’s Application BL O/038/00 3.45
Neo-Inhalation Products Limited’s Application BLO/154/13 118.13
Nestec SA & Ors v Dualit Ltd & Ors [2013] EWHC 923 (Pat) 5.25.2, 15.22, 60.12.3
Neurim Pharmaceuticals (1991) Ltd v Generics (UK) Ltd [2022] EWCA Civ 359 67.04
nifedipine see Bayer  
Nikken Kosakusho Works v Pioneer Trading Co. [2005] FSR 15, [2006] FSR 4 14.115, 14.129, 72.43, 75.21.2
Nippon Piston Ring Co Ltd’s Application [1987] RPC 120 13.09
No-Fume Ltd v Frank Pitchford Co Ltd 52 RPC 231 14.73, 14.120
Nokia Mobile Phones (UK) Ltd [1996] RPC 733 18.88
Nokia v Ipcom (Patents Court) (Court of Appeal) [2009] EWHC 3482, [2011] EWCA Civ 6 3.30.1, 14.79, 3.30.1
Nokia Corporation v IPCOM GMBH & Co KG (No. 3) [2013] RPC 5 76.15.5, 76.18.1
Nokia v Oppo [2023] EHWC 23 (Pat) 1.20.2
Norton Healthcare Ltd v Beecham Group Plc BL C/62/95 2.06
Norsk Hydro AS’s Patent [1997] RPC 89 27.26
Novartis AG v Generics (UK) Ltd (trading as Mylan) [2012] EWCA Civ 1623 3.87.2
Novartis AG v Johnson & Johnson [2009] EWCH (Pat) 1671 14.81 5.25.1
Novartis AG v Johnson & Johnson [2010] EWCA Civ 1039 14.81 5.25.1
Noxell Ltd’s Application SHB 391, BL O/137/92 76.13
NRDC’s Application [1961] RPC 134 4.02
Nutrinova Nutrition v Scanchem UK (No.2) [2001] FSR 43 62.12
NV de Bataafsche Petroleum Maatschappij’s Application 57 RPC 65 14.154
Occidental Petroleum Corporation’s Application SHB 145, BL O/35/84 4A.09
Occlutech GMBH and anr v AGA Medical Corp. and anr [2010] EWCA Civ 702 14.112
Official Ruling 1914 (A) 31 RPC Appendix i 14.100
Ogawa Chemical Industries Ltd’s Applications [1986] RPC 63 18.86
Olin Mathieson Chemical Corporation v Biorex Laboratories Ltd [1970] RPC 157 3.88
Oliver Brüstle v Greenpeace eV C-34/10 76A.02
Omron Tateisi Electronics Co’s Application [1981] RPC 125 97.04, 123.44
Omnipharm Limited v Merial [2011 EWHC 3393 (Pat) 3.87.1
Optical Coating Laboratory Inc and anr v Pilkington P. E. and anr [1995] RPC 145 3.80
Optinose’s Application BL O/144/12 20-02
Oral Health Products Inc (Halstead’s) Application [1977] RPC 612 4A.05
Organon Teknika Ltd v F. Hoffmann-La Roche AG [1996] FSR 383 74.03, 74.03.1
Osterman’s Patent [1985] RPC 579 75.05
Owens-Corning Fibreglas Corporation’s Patent [1972] RPC 684 72.14
Oxford Instruments’ Ltd’s Application SHB 248, BL O/68/93 82.04.1
Oystertec Plc’s Patent [2003] RPC 29 72.04
P’s Application [1983] RPC 269 15.18
Paez’s Application BL O/176/83 4.05
Page v Brent Toy Products Ltd (1950) 67 RPC 4 62.11
Palmaz’s European Patents (UK) [1999] RPC 47, [2000] RPC 631 76.14, 76.15.3, 125.04
Parr’s Patent SHB 282, BL O/46/94 37.19.1
Patchett’s Patent [1963] RPC 90, [1967] RPC 237 36.05, 46.35.1, 46.49
Paulus’s Patent SHB 448, BL O/73/95 28.14
Payne’s Application [1985] RPC 193 13.14, 15.56, 19.02, 117.19, 117.22
PCME Ltd v Goyen Controls Co UK Ltd [1999] FSR 801 2.28
Peabody International’s Application [1986] RPC 521 16.02
Peckitt’s Application [1999] RPC 337 72.19 123.18
Pelling and Campbell’s Application SHB 27, 32, 64, BL O/134/87 10.07
Penn Engineering & Manufacturing Corp’s Patent [1973] RPC 233 48B.12
Penn’s Patent 1357 961 SHB 112 46.58.1, 46.63, 46.71-72
Penwalt Corporation’s Application SHB 42, BL O/72/82 15.21
Pepper v Hart [1992] 3 WLR 1032 130.33
Peter Crowley v United Kingdom Intellectual Property Office [2014] unreported 4.05
Petra Fischer’s Application [1997] RPC 899 3.08
Pfizer Corp v Ministry of Health 1965] RPC 261 55.04
Pfizer Inc’s Patent 1257180 (“piroxicam”) SHB 11, BL O/78/87 46.47.2, 46.63
Pfizer Ltd’s Patent [2001] FSR 16 3.21, 3.37.1, 3.40, 4A.31
Pharmacia Corp. v Merck & Co. Inc. [2002] RPC 41 5.23
Philips (Bosgra’s) Application [1974] RPC 241 3.77
Philips Electronic and Associated Industries’ Patent [1987] RPC 244 27.11
* Philip Morris Products SA & Anor v Nicoventures Trading Ltd & Anor [2023] EWHC 2616 (Pat) 76.15.5
Pilat’s International Application [2003] RPC 13 123.37      
Pioneer Electronics Capital Inc and anr v Warner Music Manufacturing Europe GmbH and anr [1995] RPC 487 60.16      
piroxicam see Pfizer        
Plastus Kreativ AB v Minnesota Mining and Manufacturing Co [1995] RPC 438 71.07      
PLG Research v Ardon International Ltd [1993] FSR 197 2.29, 3.80      
PLG Research Ltd and anr v Ardon International Ltd and others [1995] RPC 287 3.23      
Pottier’s Application [1967] RPC 170 14.153      
Pozzoli SPA v BDMO SA [2007] EWCA Civ 588 [2007] All ER (D) 275 (JUN) 3.12, 3.13, 3.97      
Prendergast’s Applications [2000] RPC 446 3.87, 4A.29, 14.152      
Price v Elf Print Media Ltd Patents Court,1 February 2001, unreported [2001] EWCA Civ 622 40.03.2      
Pritchard’s Patent SHB 469, BL O/104/96 28.15      
Proctor & Gamble Co’s Patent 1254465 SHB 39, BL O/88/88 46.48      
Prosyscor Ltd v Netsweeper Inc & Ors [2019] EWHC 1302
(IPEC)
39.07      
Protecting Kids the World Over (PKTWO) LTD’s Patent application [2012] RPC 13 1.39.1      
Protoned BV’s Application [1983] FSR 110 76.13.1      
PyMah Corporation’s Patent SHB 336, BL O/68/95 46.60      
Q Software Global Ltd’s Application BL O/120/11 1.38.4      
Qualcomm Inc v Nokia Corp [2008] EWHC 329 (Pat) 2.12.2      
Quantel’s Patents SHB 149, BL O/128/90 48B.04, 48B.12      
Quantel v Spaceward Microsystems [1990] RPC 83 2.28      
R. v Comptroller-General of Patents, ex parte Archibald Kenrick & Sons Ltd [1994] RPC 635 97.04.1      
R. v Comptroller-General of Patents, ex parte Ash & Lacey Building Products Ltd [2002] RPC 46 72.26, 72.27      
R. v Comptroller-General of Patents, ex parte Bayer AG BL C/56/85 46.22      
R. v Comptroller-General of Patents, ex parte Celltech Ltd [1991] RPC 475 97.04.1, 117.07      
R. v Comptroller-General of Patents, ex parte Drazil [1992] RPC 479 97.04.1, 117.07      
R. v Comptroller-General of Patents, ex parte Penife International Ltd [2004] RPC 37 14.48, 97.04.1      
R. (on the application of Rjm) (Fc) v Secretary of State for Work and Pensions Appellate [2008] UKHL 63 0.10      
Raleigh Cycle Co Ltd and Anr v Miller and Co Ltd 65 RPC 141 14.125.1, 14.146      
Ranger Services Application BL O/362/09 18.09.5      
Ratiopharm GmbH v Napp Pharmaceutical Holdings [2009] RPC 11 3.33.1      
Raychem Corp.’s Patents [1999] RPC 497, [1998] RPC 31 3.30, 3.30, 3.93      
Raychem Ltd’s Application [1986] RPC 547 14.151, 76.17      
Raytheon Company v Comptroller General of Patents, Designs and Trade Marks [2007] EWHC 1230 (Pat) 1.16      
Really Virtual Co Ltd v UK Intellectual Property Office [2013] RPC 3 1.37.2      
Rediffusion Simulation v Link-Miles [1993] FSR 369 27.08      
Reed v Sir James Laing & Sons Ltd BL C/74/96 27.05.2, 73.10      
Regen Lab SA v Estar Medical Ltd & Ors [2019] EWHC 63 (Pat) 2.14      
REEF Trade Mark [2003] RPC 5 97.03      
Regeneron Pharmaceuticals Inc v Genentech Inc (Patents Court) [2012]EWHC 657 (Pat) 14.77, 14.84, 4A.29.5, 4A.30      
Regeneron pharmaceuticals Inc, Bayer Pharma AG v Genentec Inc (Court of Appeal) [2013] EWCA Civ 93 14.84, 4A.29.3, 4A.29.5, 4A.30      
Regeneron Pharmaceuticals Inc v Kymab Ltd [2020] UKSC 27 14.82.1, 14.84      
Regeneron Pharmaceuticals v Kymab Ltd [2018] EWCA Civ 671 14.66.1      
Re K (Infants) [1963] Ch 381 118.13      
Reiss Engineering Co Ltd v G J Harris [1987] RPC 171 275.02      
Reiss Engineering’s Patents SHB 2, BL O/180/86 28.16      
Research Corp’s (Carboplatin) Patent [1990] RPC 663 46.41-42, 46.45, 46.48, 46.53, 46.55      
Research In Motion UK Ltd. v Inpro Licensing SARL [2006] EWHC 70 (Pat) 1.12      
Rhône-Poulenc’s Patent 1164585 (“ketoprofen”) BL O/46/85, [1989] RPC 561 46.73, 46.76.1      
Rhône-Poulenc Santé’s European Patent (UK) [1996] RPC 125 80.03      
Richardson-Vicks Inc.’s Patent [1995] RPC 568 3.91, 76.06      
Richco Plastic Co’s Patent [1989] RPC 722 48.15      
Rigcool Ltd v Optima Solutions UK Ltd BL O/149/11 37.20.1, 123.10.1      
Rigcool Ltd v Optima Solutions UK Ltd BL O/182/11 123.10.1      
Robinson’s Application BL O/336/08 4.05.2, 14.90      
Rock Shing Industrial Ltd v Brau AG SHB 309, BL O/138/94 19.04      
Rodi and Wienenberger AG v Henry Showell Ltd [1966] RPC 441, [1969] RPC 367 14.135, 60.09      
Rohde and Schwarz’s Application [1980] RPC 155 17.94.4, 17.94.10, 17.96.1      
Ronson Products Ltd v A Lewis & Co (Westminster) Ltd [1963] RPC 103 62.10      
Rotocrop International v Genbourne [1982] FSR 241 27.11      
Roussel-Uclaf (Clemence & le Martret’s) Patent [1987] RPC 109 [1989] RPC 405 46.15-16, 46.21      
Roussel-Uclaf (Joly and Warmant’s) Patent [1971] RPC 304 72.16      
Rovi Solutions Corporation & Anor v Virgin Media Ltd & Ors [2014] EWHC 1559 (Pat) 2.12.1      
Saab Seaeye v Atlas Elektronik [2017] EWCA Civ 2175 125.14      
SABAF SpA v Meneghetti SpA (Court of Appeal), SABAF SpA v MFI Furniture Centres Ltd (House of Lords) [2003] RPC 14, [2005] RPC 10 60.15, 3.17      
salbutamol see Allen and Hanburys        
Samuel’s Patent 1594996 SHB 322 28.13      
Sandvik Intellectual Property AB v Kennametal UK Ltd [2011] EWHC 3311 (Pat) 14.76      
Saint-Gobain PAM SA v Fusion Provida Ltd and Electrosteel Castings Ltd [2005] EWCA Civ 177, [2005] IP & T 880 3.86      
Sanders Associates’ Patent SHB 104, BL O/89/81 27.24      
Sandoz Ltd (Frei’s Application) [1976] RPC 449 3.23      
Sandoz Ltd v Teva Pharmaceutical Industries Ltd [2022] EWHC 822 (Pat) 4A.29.4.1      
Schenck Rotec GmbH v Universal Balancing Limited [2012] EWHC 1920 2.13.3.1      
Schering Agrochemicals Ltd’s Patent 1271659 SHB 47, BL O/115/88 46.51      
Schering AG’s Application [1971] RPC 337 4A.02      
Schering AG’s Application [1985] RPC 545 4A.20, 130.34      
Schering AG’s Patent [1986] RPC 30 118.13      
Schering AG’s Patent 1193998 (ABM Chemicals Ltd’s Application) BL O/133/87 46.26, 46.51, 46.60, 46.69.1      
Schering Biotech Corp’s Application [1993] RPC 249 14.142-142.1, 14.149, 14.152      
Schlumberger Holdings Ltd v Electromagnetic Geoservices AS [2010] EWCA Civ 819 [2010] RPC 33 3.28-28.1, 3.81, 14.64,14.152      
Schütz (UK) Ltd v Werit UK Ltd (Patents Court) [2010] EWHC 660 60.12.2      
(Court of Appeal) [2011] EWCA Civ 303 60.12.2      
(Supreme Court) [2013] UKSC 16 60.12.2-60.12.3      
Schütz (UK) Ltd v Werit UK Ltd & Anr [2011] EWCA Civ 927 68.08      
Schwarzkopf and Ors’ Application 31 RPC 437 14.78      
Schwarzkopf’s Application [1965] RPC 387 7.05      
Scragg (Ernest) Ltd’s Application [1972] RPC 679 72.19      
Secretary of State for Education and Skills v Frontline Technology Limited [2005] EWHC 37 (Ch) 14.127.1, 130.26      
See Real Technologies SA BL O/261/12 18.97      
Shahin’s Application SHB 456, BL O/149/95 1.30      
Shanks v Unilever (Patents Court)
(Court of Appeal)
[2010] RPC 11 [2011] RPC 12 41.04.1      
Shanks v Unilever Plc & Ors (Hearing)
(Patents Court)
(Court of Appeal)
Supreme Court
BL O/259/13 [2014] EWHC 1647 (Pat)
[2017] EWCA Civ 2
[[2019] UKSC 45
40.04.2, 41. 04      
Shape and Potemkin’s Applications SHB 211, BL O/140/92 8.23      
Shell Development Co’s Application 64 RPC 154 14.152      
Shiley Inc’s Patent 1303864 [1988] RPC 97 46.50, 46.58, 46.63, 46.65, 46.76      
Shopalotto.com Ltd’s Application [2006] RPC 7 1.20.3, 1.32, 17.98      
Siegfried Demel v C & H Jefferson [1999] FSR 204 76.26      
Siemens Medical Systems Inc.’s Application BL O/063/00 14.200      
Singleton’s Patent 1395 858 SHB 323 28.13      
Sirna Therapeutics Inc’s Application [2006] RPC 12 5.26.4, 5.26.5, 20A.13, 20A.14, 28.09, 28.09.1      
Smart Card Solutions Ltd’s Applications [2004] RPC 12 18.56      
Smith International Inc’s Patent [2006] FSR 25 97.08      
Smith & Nephew’s Patent 1280631 SHB 22, BL O/126/87 46.50.1, 46.55, 46.64, 46.73, 46.76.3      
Smith & Nephew Plc v Convatec Technologies Inc [2015] EWCA Civ 607 14.117.2-3      
Smith, Kline and French Laboratories Ltd v Evans Medical Ltd [1989] FSR 513, [1989] FSR 561 60.25, 27.08, 75.04      
Smith, Kline and French Laboratories Ltd v R D Harbottle (Mercantile) Ltd and Others [1980] RPC 363 60.13 14      
Smith, Kline and French Laboratories Ltd’s Cimetidine Patents 1338169 and 1397436 (Generics’ Application) [1990] RPC 203, [1988] RPC 148 46.35-37.2, 46.38, 46.39.1, 46.42, 47.1, 46.48, 46.54, 46.55.1-56, 46.70, 46.16, 46.21      
Smith, Kline and French Laboratories Ltd’s Patents 1338169, 1395929, 1397436 and 1398426 (Harris Pharmaceuticals’ Application) [1990] RPC 203 46.16      
Smith, Kline and French Laboratories Ltd’s Patents 1338169 and 1397436 (Ivax Corp’s Application) SHB 114 46.47.1, 46.70, 46.73      
SmithKline Beecham plc’s Patent [2003] RPC 6 2.35      
SmithKline Beecham Plc’s (Paroxetine Methanesulfonate) Patent [2006] RPC 10 2.02, 2.06.2 2.07.2-3, 2.08, 2.10-10.1      
SmithKline Beecham Plc v Apotex Europe Ltd (No.2) [2005] FSR 24 63.04, 65.06      
Societe Minerve SA’s Patent 1445 469 SHB 315, BL O/55/82 28.11      
Sonic Tape plc’s Patent [1987] RPC 251 130.22, 280.04      
Sony Corporation’s Patent [1990] RPC 152 28.12      
Southco Inc v Dzus Fastener Europe Ltd [1990] RPC 587 76.13.1, 76.20      
Spring Form Inc. v Toy Brokers Ltd [2002] FSR 17 69.06      
Stanelco Fibre Optics Ltd’s Applications [2005] RPC 15 7.12.1, 7.12.4      
Starsight Telecast Inc & Anor v Virgin Media Ltd & Ors [2014] EWHC 828 (Pat) 76.15.5      
Statoil ASA v University of Southampton BL O/204/05 7.12.2, 7.12.4, 8.09      
Stena Rederi Aktiebolag v Irish Ferries Ltd[2002] RPC 50, [2003] RPC 36 60.26      
Stephen L Thaler’s application BL O/741/19 7.11.1, 13.10.1      
Stevens’ Application SHB 241, BL O/63/93 8.23      
Sudarshan Chemical Industries Ltd v Clariant Produkte (Deutschland) GmbH [2014] RPC 6 14.127      
Sunwave Communications Co. Ltd BL O/0206/23 117-09      
Symbian Ltd’s Application [2008] EWCA Civ 1066, [2009] RPC 1 1.09.1, 1.09.3, 1.16, 1.24, 1.35, 1.37, 1.37.1, 1.38.4      
Syntex Corporation’s Patent (“naproxen”) [1986] RPC 585 46.38.1, 46.61, 46.68      
Szucs’ Application SHB 106, BL O/004/86 8.21.1      
Tanabe Seiyaku Co’s Patent 1236467 (“diltiazem”) BL O/140/86 46.47, 46.62      
Tate & Lyle Technology v Roquette Frères (Patents Court) Tate & Lyle Technology v Roquette Frères (Court of Appeal) [2010] FSR 1 [2010] EWCA Civ 1049 1.27, 2.14.1      
Taylor v Lanarkshire Health Board BL O/864/21 36.07      
Taylor v Lanarkshire Health Board BL O/157/22 36.07      
TDK Electronics Co Ltd’s Application SHB 103, BL O/97/83 1.40.2      
Technetix B.V and others v Teleste Ltd [2019] EWHC 126 125.17.8      
Technip France SA’s Patent [2004] RPC 46 3.21      
Tekdata Ltd’s Patent 1553 575 [1985] RPC 201 28.12      
Telsonic AG’s Patent [2004] RPC 38 14.135      
Tetra Moletric Ltd v Japan Imports Ltd [1976] RPC 547 3.26, 3.81.1      
Teva Pharmaceutical Industries Ltd & Ors v Bayer Healthcare LLC [2021] EWHC 2690 (Pat) 3.87.2      
Teva UK Limited & another v AstraZeneca AB EWHC 2873 2.08, 3.30.0, 76.15.5      
Teva UK Ltd and others v AstraZeneca AB [2012] EWHC 655 3.99      
* Teva Pharmaceutical Industries Ltd v Astellas Pharma Inc.
Teva Pharmaceutical Industries Ltd & Anor v Astellas Pharma Inc
[2022] EWHC 1316 (Pat)
[2023] EWCA Civ 880
3.87.3      
Texas Iron Works v Nodeco [2000] RPC 207 62.03, 76.05      
Textron Inc’s Patent [1989] RPC 441 28.12      
Thaler v Comptroller-General of Patents [2020] EWHC 2412 (Pat) [2021] EWCA Civ 1374 7.11.1, 13.09, 13.10.1      
** Thaler v Comptroller-General of Patents, Designs and Trade Marks [2023] UKSC 49 7.11.1, 13.09, 13.10.1      
Thaler’s Application BL O/447/22 13.12.1, 89.B.07.1      
Therma-Tru Corporation’s Patent BL O/92/96 50.05, 50.07      
Three Delayed Convention Applications [1975] RPC 611 119.03      
Threeway Pressings Ltd’s Application [2012] RPC 129 BL O/124/12 2.38      
timolol see Frosst        
Tokan Kogyo KK’s Application [1985] RPC 244 117.01, 123.03      
Torre’s Patent SHB 356 BL O/146/95 46.37.4, 46.62, 46.72.1      
Townsend’s Application BL O/266/03, [2004] EWHC 482 (Pat) 1.40, 1.40.2      
triazolam see Upjohn        
Triten Corp’s Patent SHB 45, BL O/65/88 28.16      
Ultimatte Corp’s Patent SHB 101, BL O/1/84 48.13      
Ultraframe (UK) Ltd v Eurocell Building Plastics Ltd [2005] RPC 7 14.111      
Ultraframe (UK) Ltd v Fielding [2004] RPC 24 39.12.1      
Unilever Ltd (Davis’) Application [1983] RPC 219 0.05, 4A.02, 4A.09      
Unilever plc v Chefaro Proprietaries Ltd [1994] RPC 567 3.34      
Unilin Beheer BV v Berry Floor NV [2004] EWCA (Civ) 1021 5.23.3      
Unilin Beheer BV v Berry Floor NV and Others [2007] EWCA Civ 364 61.04.2      
Unilin Beheer BV v Berry Floor NV (No.2) [2006] FSR 26 62.13      
Union Carbide Corporation (Hostettler’s) Application [1972] RPC 601 3.94      
Union Carbide Corp. v BP Chemicals Ltd [1999] RPC 409, [1998] RPC 1 125.05, 2.06.1, 2.18      
Unique Products and Design Co Ltd’s Application SHB 453, BL O/147/95 89.10      
Unitec Systems’ Application SHB 247, BL O/143/94 39.12      
United Shoe Machinery’s Application 57 RPC 71 14.148      
United Wire Ltd v Screen Repair Services (Scotland) Ltd [2001] RPC 24 60.12.1-3      
Universite Rene Descartes SHB 293, BL O/147/88 14.151      
University of Chicago’s Patent SHB 353, BL O/44/91 28.12      
University of Southampton’s Applications [2002] RPC 44 12.05.1      
University of Southampton’s Applications [2005] RPC 11, [2006] RPC 21 7.12.3, 7.13, 8.06      
Uniworld Trade and Finance Establishment’s Patent 1521254 SHB 318 28.16      
Unwired Planet International Ltd v Huawei Technologies Co Ltd & Ors [2015] EWHC 3366 2.22.1      
Upjohn Co (Beal’s) Patent [1973] RPC 77 27.15      
Upjohn Co (Kirton’s) Application [1976] RPC 324 4A.10      
Upjohn’s Patents 1291631 and 1291632 (“triazolam”) (Generics Ltd’s application) BL C/70/88 46.37.2, 46.48      
Upjohn’s Patent 1291632 SHB 8, 19, BL O/40/87, BL O/102/87 46.17      
Upjohn’s Patent 1291631 (“triazolam”) and Takeda Chemical Industries’ Patent 1298364 (Generics Ltd’s application) SHB 4, BL C/49/87 46.34      
Valensi and another v British Radio Corporation Ltd [1973] RPC 337 14.68-14.69      
Van der Lely NV v Bamfords Ltd [1963] RPC 61 60.07      
Van der Lely’s Application [1987] RPC 61 76.15.1      
Vause’s European Patent BL O/278/00 28.05      
VEB Kombinat Walzlager und Normteile’s Application [1987] RPC 405 15.08, 76.08.1      
Vector Corp V Glatt Air Technologies Ltd [2007] RPC 12 27.07, 76.15.4      
Vernacare Ltd v Moulded Fibre Products (MFP) [2022] EWHC 2197 (IPEC)
[2023] EWCA Civ 831
3.26.1, 3.95, 125.17.8, 125.18.8      
Virgin Atlantic Airways Ltd v Premium Aircraft Interiors UK Ltd [2009] EWCA Civ 1062, [2010] RPC 8 1.19, 14.112, 14.135      
Virgin Atlantic Airways Limited v Zodiac Seats UK Limited [2013] UKSC 46 61.04.2      
Virulite Ltd’s Application BL O/058/10 4A.09      
VNU Business Publications BV v Ziff Davis (UK) Limited [1992] RPC 269 118.13      
Waddingtons Ltd’s Patent [1986] RPC 158 27.07      
Wake Forest University Health Sciences & Ors v Smith & Nephew Plc & Anor [2009] EWCA Civ 848 3.37.1      
Walters’ Patent SHB 362, BL O/105/91 28.15      
Ward’s Applications BL O/143/02, BL O/055/06 17.96.4      
Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Ors (Court of Appeal) [2015] EWCA Civ 556 4A.31, 60.16.1, 60.19.2      
Warner-Lambert Company v Generics (UK) Ltd (t/a Mylan) & Ors (Court of Appeal) [2016] EWCA Civ 1006 4A.31, 60.16.1, 60.19.2      
Warner-Lambert Company LLC v Generics (UK) Ltd (t.a. Mylan) & Anor. (Supreme Court) [2018] UKSC 56 4A.27.1, 4A.29.4-5, 4A.31, 14.72.1, 60.16.1, 60.19.2, 75.21.2, 125.14      
Warwick’s Patent 1444 979 SHB 317, BL O/150/82 28.14      
Waters Investments Ltd’s Application BL O/146/07 1.29.2      
Webb’s Application BL O/84/88 4.05      
Wellcome Foundation Ltd v VR Laboratories (Australia) Pty Ltd [1982] RPC 343 3.04      
WesternGeco Ltd’s Application BL O/135/07 1.29.2      
Wheatley v Drillsafe Ltd [2001] RPC 7 3.16 Wheatley’s Application [1985] RPC 91 2.28
Whiteside’s Patent 1467 044 SHB 321, BL O/44/84 28.13, 28.16      
Wilkinson Sword Ltd v Gillette Industries Ltd & Anr [1975] RPC 101 27.08      
Wills’ Application BL O/89/99 1.33.2      
Windsurfing International Inc v Tabur Marine (Great Britain) Ltd [1985] RPC 59 3.05, 3.11, 3.23, 3.34, 3.76      
WMS Gaming Ltd’s Application BL O/260/13 1.20.2      
Wobben v Vestas-Celtic Wind Technology Ltd [2007] EWHC 2636 (Pat) 14.60      
Woolard’s Application [2002] RPC 39 2.32, 73.02.2      
J Wyeth and Brother Ltd’s Application [1985] RPC 545 4A.20      
Xu’s Application BL O/610/22 20.02      
Yeda Research and Development Co Ltd v Rhone-Poulenc Rorer International Holdings Inc. [2007] RPC 9 37.20      
Yeda Research and Development Co Ltd v Rhone- Poulenc Rorer International Holdings Inc. and others [2007] UKHL 43 8.06, 37.20      
Zannetos’s Application SHB 474, BL O/119/96 18.24      
Zarach’s Patent 1578 074 SHB 319 28.12      
Zebra Technologies Corporation’s Application O/653/22 2.08.1      
Zeigler’s Patent BL O/64/87 1.02      
Zipher Ltd v Markem Systems Ltd & Anr [2008] EWHC 1379 (Pat) 14.60-14.61, 14.64, 14.67, 14.76, 27.08, 27.32, 27.32.1, 75.04, 75.21, 75.21.1      

EPO Decisions referred to in the Manual

Decision reference EPO decision type
G decision of the EPO Enlarged Board of Appeal
J decision of the EPO Legal Board of Appeal
T decision of the EPO Technical Board of Appeal
V decision of the EPO Opposition Division
Decision reference Decision number Case Citation Manual Paragraph(s)
G 01/19 (Pedestrian simulation) 1.29.5  
G 05/83 [1985] 3 OJEPO 64 Eisai/ Second medical indication 4A.20, 4A.27, 4A.28
G 02/88 correction [1990] 4 OJEPO 93 [1990] 12 OJEPO 469 Mobil Oil Corp 2.14
G 06/88 [1990] 4 OJEPO 114 Bayer A G 2.14
G 11/91 [1993] 3 OJEPO 125 Celtrix 117.07
G 01/92 [1993] 5 OJEPO 277   2.27
G 01/93 [1994] 8 OJEPO 541 Adv Semiconductor 18.69, 76.14, 76.27
G 03/93 [1995] 1-2 OJEPO 18   6.03
G 01/98 [2000] EPOR 303 Novartis 76A.05
G 02/98 [2001] 10 OJEPO 413 [2002] EPOR 17 Requirement for claiming priority of the “same invention” 5.25
G 01/03 and 02/03 [2004] 8-9 OJEPO 413 [2004] EPOR 33 Disclaimer/PPG Disclaimer/Genetic Systems 14.127-14.127.1
G 01/04 [2006] 5 OJEPO 334 [2006] EPOR 15 Diagnostic Methods 4A.06
G 2/06 [2009] 5 OJEPO 306 WARF Use of embryos 76A.02.1
G 01/07 [2011] 3 OJEPO 134 Medi-Physics/ Treatment by surgery 4A.08, 4A.10, 4A.11.1, 4A.14
G 02/07   State of Israel/ Broccoli 76A.03
G 01/08   State of Israel/ Tomatoes 76A.03
G 02/08 [2010] 10 OJEPO 456 Abbott Respiratory Dosage regime 4A.27-4A27.1, 4A.28.2
G 03/08   Patentability of programs for computers 1.09.2
G 02/10   Disclaimer/SCRIPPS 14.127,4A.14
G 01/15   Infineum USA L.P. 5.25.3
G 01/16   Disclaimer 14.127
G 01/19   Pedestrian simulation 1.29.1
J 22/88 [1990] 5 OJEPO 244 Radakovic 28.15.1
J 02/01 [2005] 2 OJEPO 88 [2004] EPOR 54 Trustees of Dartmouth College 15.24
T 02/80 [1981] 10 OJEPO 431 Bayer AG 14.128
T 36/82 [1983] 7 OJEPO 269 Cselt 3.04
T 110/82 [1983] 7 OJEPO 274 Bayer AG 14.159.1
T 119/82 [1984] 5 OJEPO 217 Exxon Research & Eng Co 3.82
T 150/82 [1984] 7 OJEPO 309 International Flavors and Fragrances Inc 2.15, 14.121
T 06/83 [1990] 1-2 OJEPO 5 IBM 1.09.4, 1.37.1
T 84/83 [1979-85] EPOR 796 Luchtenberg GmbH 2.27
T 201/83 [1984] 10 OJEPO 481 Shell 76.07
T 204/83 [1985] 10 OJEPO 310 Charbonnages 2.08.1
T 176/84 [1986] 2 OJEPO 50 Mobius Metallwarenfabrik 3.44
T 26 163/85 [1990] EPOR 599 BBC/Colour television signal 1.40.1
T 5/86 unreported Newman 4.05
T 26/85 [1990] EPOR 267 Toshiba/Thickness of Magnetic Layers 2.06.2
T 115/85 IBM/Computer-related inventions)   1.09.4, 1.36, 1.37.1, 1.37.3
T 208/84 [1987] 1 OJEPO 14 (Vicom Systems Inc) 1.09.4, 1.29-1.29.2, 1.37.1, 1.38.1
T 303/86 [1993] EPOR 241 CPC Int 2.04.1
T 427/86 [1999] EPOR 443 Rhône-Poulenc 2.19
T 35/87 [1988] 4 OJEPO 134 BASF 14.163
T 301/87 [1990] 8 OJEPO 335 Biogen 14.149
T 331/87 [1991] EPOR 194 Houdaille/Removal of feature 76.18.1
T 344/89 [1993] EPOR 209 GTE Laboratories 76.14
T 666/89 [1992] EPOR 501 Unilever/Washing Composition 2.06.2
T 482/89 [1992] 11 OJEPO 646 Telemechanique 2.27
T 19/90 315/03 [1990] 12 OJEPO 476 [2006] 1 OJEPO 15 Harvard College T 1.35, 76A.02.1, 76A.05
T 122/90 unreported Raychem Ltd 76.17
T 303/90 unreported Victoria University Manchester 4A.17
T 401/90 unreported Victoria University Manchester 4A.17
T 409/91 [1994] 9 OJEPO 653 Exxon 14.81
T 435/91 [1995] 4 OJEPO 188 Unilever 14.81
T 694/92 [1997] OJEPO 408 Mycogen 14.81
T 820/92 [1995] 3 OJEPO 113 The General Hospital Corp’s Application 4A.02
T 939/92 [1996] 6 OJEPO 309 AgrEvo UK Ltd 3.89, 3.90, 14.142.1
T 952/92 [1995] 11 OJEPO 755 Packard Instrument BV 2.27
T 74/93 [1995] 10 OJEPO 712 British Technology 4A.02
T 356/93 [1995] 8 OJEPO 545 Plant Genetic Systems 1.35
T 207/94 [1999] EPOR 451 Biogen 5.25
T 892/94 [2000] 1 OJEPO 1 Robertet SA 2.14
T 609/02   Salk Institute 4A.29.2-3
T 258/03 [2004] 12 OJEPO 575 [2005] EPOR 55 Hitachi/Auction Method 1.37.1
T 315/03 [2006] 1 OJEPO 15 [2005] EPOR 31 Harvard College 1.35, 76A.02.3, 76A.05
T 383/03 3 OJEPO [2005] 159 General Hospital/ Hair removal method 4A.09
T 1329/04 [2006] EPOR 8 Johns Hopkins University School of Medicine/Growth Differentiation Factor 3.91
T 250/05   Brigham and Women’s Hospital 4A.27.1
T 1054/05   NEC Corp. 3.17
T 1134/06   Konami Corp. 18.09.4
T 1743/06   INEOS Silicas 14.81, 14.88
T 1553/06   Public availability of documents on the World Wide Web/PHILIPS 2.24.1
T 1758/07   Biotech Pharmacon 4A.22, 4A.31
T 0002/09   Public availability of an e-mail transmitted via the Internet/PHILIPS 2.24.2
T 1099/09   Coloplast 4A.22, 4A.28-3
T 1496/11   Securency International Pty Ltd 15.22
T 879/12   Genentech 4A.27.1, 18.97.1
T 1780/12   Board of Regents, the University of Texas System 4A.27.1, 18.97.1
T 1218/14   Dohler/Du Pont Nutrition Biosciences 14.127, 14.88
V 08/94 [1995] 6 OJEPO 388 Howard Florey Institute of Experimental Physiology/ Relaxin 76A.06